A recent study published in the journal Vaccine has identified potential adverse events associated with various Covid-19 vaccines, raising concerns about rare but serious side effects.
The study examined 13 medical conditions considered “adverse events of special interest” in a staggering 99 million vaccinated individuals across eight countries. Researchers found that myocarditis, inflammation of the heart muscle, was consistently identified as a potential risk following mRNA vaccines, particularly after a second dose of the Moderna vaccine.
Guillain-Barre syndrome, a rare neurological disorder, was linked to viral-vector vaccines developed by Oxford University, with 190 cases observed compared to an expected 66. Additionally, cerebral venous sinus thrombosis, a type of blood clot in the brain, was found to be three times more likely after the Oxford-developed vaccine compared to mRNA vaccines.
The study also highlighted risks of transverse myelitis and acute disseminated encephalomyelitis after both viral-vector and mRNA vaccines. Researchers at the Yale School of Medicine found that over 240 adults experienced chronic post-vaccination syndrome, with symptoms like exercise intolerance, fatigue, and brain fog. The cause of this syndrome is unknown and there are currently no proven remedies.
Despite the potential risks identified, researchers stressed the importance of vaccines in saving millions of lives. They emphasized the need to consider the potential adverse effects on a small number of individuals to ensure vaccine safety and alleviate the suffering of those affected.
The study aimed to improve understanding of these adverse events to enhance vaccine safety measures and ultimately protect public health. As the global vaccination campaign continues, researchers urge vigilance in monitoring and addressing potential risks associated with Covid-19 vaccines.
“Devoted bacon guru. Award-winning explorer. Internet junkie. Web lover.”
